Literature DB >> 8292999

Characterization of Pneumocystis carinii preparations developed for lipid analysis.

E S Kaneshiro1, M A Wyder, L H Zhou, J E Ellis, D R Voelker, S G Langreth.   

Abstract

Pneumocystis carinii organisms were isolated from viral antibody-negative rats that had been infected by intratracheal intubation of organism preparations tested negative for common bacteria and fungi. Infection scores of lungs from infected animals at the time of parasite isolation was > 5 (100-1,000 organisms/oil immersion field). Electron microscopy of heavily infected lungs revealed that the pathogens adhered to Type I pneumocytes and to each other, resulting in obstructions up to several cell layers thick, which extended into the alveolar lumen. Protocols for purifying the organisms were developed to optimize separation from each other and from host cells, and to optimize preparation purity, recovery efficiency, and organism viability. The study tested mucolytic agents, sieving, various centrifugation speeds, lysis of host cells by osmotic shock and filtration through membranes of different pore diameter. Final preparations contained no intact host cells as determined by light microscopy. Only minor amounts (< 5%) of host debris were detected by electron microscopy. Most organisms and their pellicles were ultrastructurally intact but no longer adhered to one another. The final preparation was characterized biochemically by quantitation of the specific lung surfactant marker surfactant protein A, which indicated > 99.5% purity. The total non-P. carinii protein in the final preparation (< 6%, depending on the level of infection) was estimated by the protein content of pelletable material resulting from processing uninfected lungs in an identical manner. Elimination of free cholesterol and phospholipids from host lung tissue was monitored during the purification process. Exogenous stigmasterol, added as an extracellular marker, decreased during the purification process and was undetectable in the final organism preparation. Yields of 10(8)-10(9) organisms/rat were routinely obtained. Viability, assessed by the calcein acetoxymethyl ester-propidium iodide assay, was 80-95%.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8292999     DOI: 10.1111/j.1550-7408.1993.tb04479.x

Source DB:  PubMed          Journal:  J Eukaryot Microbiol        ISSN: 1066-5234            Impact factor:   3.346


  16 in total

1.  Characterizations of neutral lipid fatty acids and cis-9,10-epoxy octadecanoic acid in Pneumocystis carinii carinii.

Authors:  E S Kaneshiro; J E Ellis; Z Guo; K Jayasimhulu; J N Maiorano; K A Kallam
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

2.  Ubiquinone synthesis in mitochondrial and microsomal subcellular fractions of Pneumocystis spp.: differential sensitivities to atovaquone.

Authors:  Mireille Basselin; Shannon M Hunt; Hiam Abdala-Valencia; Edna S Kaneshiro
Journal:  Eukaryot Cell       Date:  2005-08

3.  Sterols of Pneumocystis carinii hominis organisms isolated from human lungs.

Authors:  E S Kaneshiro; Z Amit; J Chandra; R P Baughman; C Contini; B Lundgren
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

4.  C27 to C32 sterols found in Pneumocystis, an opportunistic pathogen of immunocompromised mammals.

Authors:  E S Kaneshiro; M A Wyder
Journal:  Lipids       Date:  2000-03       Impact factor: 1.880

Review 5.  The lipids of Pneumocystis carinii.

Authors:  E S Kaneshiro
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

6.  Phytosterols are present in Pneumocystis carinii.

Authors:  S T Furlong; J A Samia; R M Rose; J A Fishman
Journal:  Antimicrob Agents Chemother       Date:  1994-11       Impact factor: 5.191

7.  Pneumocystis pneumonia increases the susceptibility of mice to sublethal hyperoxia.

Authors:  James M Beck; Angela M Preston; Steven E Wilcoxen; Susan B Morris; Eric S White; Robert Paine
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

8.  Phospholipid composition of Pneumocystis carinii carinii and effects of methylprednisolone immunosuppression on rat lung lipids.

Authors:  Z Guo; E S Kaneshiro
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

9.  Pneumocysterol [(24Z)-ethylidenelanost-8-en-3beta-ol], a rare sterol detected in the opportunistic pathogen Pneumocystis carinii hominis: structural identity and chemical synthesis.

Authors:  E S Kaneshiro; Z Amit; M M Swonger; G P Kreishman; E E Brooks; M Kreishman; K Jayasimhulu; E J Parish; H Sun; S A Kizito; D H Beach
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-05       Impact factor: 11.205

10.  Use of an ATP bioluminescent assay to evaluate viability of Pneumocystis carinii from rats.

Authors:  F Chen; M T Cushion
Journal:  J Clin Microbiol       Date:  1994-11       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.